• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharmaceuticals

RCPT:US

41.9500 USD 1.2200 3.00%

As of 14:18:14 ET on 07/30/2014.

Snapshot for Receptos Inc (RCPT)

Open: 41.2200 Day's Range: 40.3500 - 41.9700 Volume: 146,179
Previous Close: 40.7300 52wk Range: 15.2100 - 55.0000 1-Yr Rtn: +112.73%

Stock Chart for RCPT

No chart data available.
  • RCPT:US 41.9399
  • 1D
  • 1M
  • 1Y
40.7300
Interactive RCPT Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for RCPT

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -3.7300
Est. EPS (USD) (12/2014) -4.1080
Est. PEG Ratio -
Market Cap (M USD) 1,082.73
Shares Outstanding (M) 26.61
30 Day Average Volume 513,751
Price/Book (mrq) 6.5946
Price/Sale (ttm) 142.9155
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 08/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for RCPT

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for RCPT

Receptos, Inc. discovers and develops small molecule drug therapies. The Company specializes in the development of G protein-coupled receptors therapeutic candidates in the United States. Receptos focuses on the discovery, development, and commercialization of various therapeutics for immune disorders.

Faheem HasnainPresident/CEOGraham K CooperChief Financial Officer
Marcus F BoehmChief Technology OfficerRobert J PeachChief Scientific Officer
More Company Profile & Key Executives for RCPT

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil